CP
ABBV icon

Camelot Portfolios’s AbbVie ABBV Stock Holding History

Camelot Portfolios’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,016
Closed -$323K – 224
2020
Q4 		$323K Sell
3,016
-279
-8% -$26.8K 0.17% 150
2020
Q3 		$289K Sell
3,295
-336
-9% -$31.6K 0.18% 145
2020
Q2 		$356K Sell
3,631
-3,018
-45% -$266K 0.23% 116
2020
Q1 		$507K Buy
6,649
+852
+15% +$72.6K 0.28% 94
2019
Q4 		$513K Buy
5,797
+952
+20% +$79K 0.22% 116
2019
Q3 		$367K Buy
4,845
+476
+11% +$32.6K 0.17% 136
2019
Q2 		$318K Sell
4,369
-307
-7% -$24.1K 0.13% 169
2019
Q1 		$377K Sell
4,676
-29
-0.6% -$2.37K 0.16% 153
2018
Q4 		$434K Sell
4,705
-2,551
-35% -$224K 0.2% 128
2018
Q3 		$686K Buy
7,256
+56
+0.8% +$5.31K 0.31% 91
2018
Q2 		$667K Hold
7,200
– – 0.28% 95
2018
Q1 		$681K Buy
7,200
+1,302
+22% +$143K 0.32% 87
2017
Q4 		$570K Buy
5,898
+600
+11% +$56.5K 0.27% 90
2017
Q3 		$471K Hold
5,298
– – 0.23% 95
2017
Q2 		$384K Buy
+5,298
New +$356K 0.19% 105
2015
Q3 		– Sell
-3,763
Closed -$253K – 152
2015
Q2 		$253K Buy
3,763
+263
+8% +$17.2K 0.15% 136
2015
Q1 		$205K Sell
3,500
-150
-4% -$9.06K 0.12% 150
2014
Q4 		$239K Hold
3,650
– – 0.14% 139
2014
Q3 		$211K Hold
3,650
– – 0.12% 146
2014
Q2 		$206K Buy
+3,650
New +$191K 0.13% 147

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Camelot Portfolios's ABBV Position: Q1 2021 in Review

Camelot Portfolios sold out of AbbVie (ABBV) in Q1 2021, closing a stake of 3,016 shares — an estimated $323K sold.

Camelot Portfolios first reported a position in ABBV in Q2 2014 and held it in 20 quarters. The position peaked at $686K in Q3 2018. 2,615 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

  • Camelot Portfolios reported no remaining AbbVie position as of Q1 2021 after selling out during the quarter.
  • Camelot Portfolios sold 3,016 AbbVie shares in Q1 2021, an estimated $323K.
  • Camelot Portfolios first reported a position in AbbVie in Q2 2014 and held it in 20 quarters.
  • Camelot Portfolios's AbbVie position peaked at $686K in Q3 2018.
  • 2,615 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on Camelot Portfolios's 13F filing for Q1 2021, filed 21 Apr 2021.